Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SK-5307 Phase I multiple-dose study in healthy adult male subjects
jRCT2071220064Phase 1Completed
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of paltusotine (2 arms), sponsored by Sanwa Kagaku Kenkyusho Co., Ltd. Primary endpoints: Safety, Pharmacokinetics and 1 more. Started Nov 2022; status: completed.
02
Drugs
paltusotine
Beyond the preview
Go deeper on jRCT2071220064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071220064.